COMMUNIQUÉS West-GlobeNewswire

MIMEDX Announces Second Quarter 2026 Operating & Financial Results
29/07/2026
Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM [...]
As Indiana's Nurse Shortage Grows, Jersey College and Lutheran Hospital Mark Five Years of Solving It Together
29/07/2026
A public event on July 30 celebrates the organizations’ efforts to reshape the local nursing workforce FORT WAYNE, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- Jersey College , the higher education institution dedicated to [...]
F6S Ranks Life Backup Plan 55th in Health and Wellness
29/07/2026
National ranking accompanies recognition from Pepperdine, TiE, ASCEND LA and two healthcare publications Aliso Viejo, CA, July 29, 2026 (GLOBE NEWSWIRE) -- F6S ranks Life Backup Plan® 55th on its, “ 100 Top Health [...]
CorVascular to Showcase DuplexABI™ Solution at SVU 2026 Annual Conference & Marketplace
29/07/2026
MINNEAPOLIS, July 29, 2026 (GLOBE NEWSWIRE) -- CorVascular today announced it will showcase its new DuplexABI™ solution at the Society for Vascular Ultrasound 2026 Annual Conference & Marketplace in National Harbor [...]
First-half 2026 results
29/07/2026
Half-Year Results: strong improvement in operating performance Successful refinancing transactions Objectives confirmed Strong improvement in operating performance Revenue as at 30 June 2026 stood at €2,699m, up +4.6% [...]
EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2026
29/07/2026
Mise à disposition du Rapport financier semestriel 2026 Paris, France (29 juillet 2026 – 18h00) – Le Conseil d’administration d’EssilorLuxottica, qui s’est réuni le 28 juillet 2026, a arrêté les comptes consolidés [...]
EssilorLuxottica: Publication of the 2026 Interim Financial Report
29/07/2026
Publication of the 2026 Interim Financial Report Paris, France (29 July 2026 – 6:00 pm) – The Board of Directors of EssilorLuxottica met on July 28, 2026 to approve the condensed consolidated interim financial [...]
Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
29/07/2026
Ipsen appoints Catherine Bradley as independent Director to its Board of Directors PARIS, FRANCE, 29 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Catherine Bradley, CBE, as an [...]
As New Research Shows Long Covid Affects 1 in 6 Patients, Apheresis Center Analysis Finds US Insurance Policies Are Driving Patients Abroad.
29/07/2026
New research doubles prior US Long Covid estimates, while US patients face insurance denials and a scarcity of domestic apheresis providers offering treatment is driving demand for international H.E.L.P. Apheresis [...]
First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site
29/07/2026
Press Release Paris, 29th July 2026 €356.5 million Net Sales, down 13.5% year-on-year as reported and -11.8% on a comparative basis 1 As expected, including a negative €13 million impact from the planned discontinuation [...]
Résultats semestriels 2026
29/07/2026
Résultats au 30 juin 2026 : forte progression de la performance opérationnelle Succès des opérations de refinancement Objectifs confirmés Forte progression de la performance opérationnelle Le chiffre d’affaires au 30 [...]
Ipsen nomme Catherine Bradley en tant que nouvelle administratrice indépendante au sein de son Conseil d’administration
29/07/2026
Ipsen nomme Catherine Bradley, administratrice indépendante au sein de son Conseil d’administration PARIS, FRANCE, 29 JUILLET 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd'hui la cooptation de Catherine [...]
Les résultats du premier semestre 2026 confirment la résilience commerciale et opérationnelle dans un environnement de marché difficile - La transformation progresse selon le calendrier avec notamment la cession du site de Brindisi
29/07/2026
Communiqué de presse Paris, le 29 juillet 2026 Chiffre d’affaires de 356,5 millions d’euros, en baisse de 13,5% par rapport au S1 2025 et de -11,8% sur une base comparable 1 Comme prévu, incluant un impact négatif de 13 [...]
SOUND Behavioral Health Launches Corporate Community Partner Program During 60th Anniversary Year
29/07/2026
SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- As SOUND Behavioral Health celebrates 60 years of serving the Puget Sound region, the organization has launched its new Corporate Community Partner Program, creating meaningful [...]
New Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side Effects
29/07/2026
A new study using Clue's menstrual tracking data finds women vaccinated during the follicular phase were more likely to self-report side effects and had a longer time to subsequent infection than those vaccinated during [...]
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
29/07/2026
PDUFA target action date of November 28, 2026, approximately one quarter ahead of Company’s previously communicated guidance FDA identified no Filing review issues Acceptance triggers $15 million milestone payment, [...]
TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages
29/07/2026
-Carbonium Merger Remains on Track -European Regulatory Expansion and Partnership Growth -Advancement of Biosafety Cabinet Standards -Defense Sector Growth FREDERICK, Md., July 29, 2026 (GLOBE NEWSWIRE) -- TOMI [...]
CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
29/07/2026
PARSIPPANY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on [...]
RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
29/07/2026
MOUNTAIN VIEW, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing [...]

Pages